The ENDVOC Consortium Calls for Funding, Research and Awareness on Long Covid and Other Post-Acute Infection Syndromes
A recently published document provides a timely update on the [...]
ENDVOC Study Finds Stronger Immune Response to SARS-CoV-2 Infection in People with Long COVID
The study, based on a population cohort in England, measured [...]
COVID-19 Vaccination Induces Long-Lasting Antibody B-cell Responses
END-VOC researchers followed a cohort of healthcare workers in Catalonia [...]
A Switch to IgG4 Antibodies After COVID-19 Vaccination May Increase the Risk of Breakthrough Infections
For over three years, ENDVOC researchers analysed the quantity and [...]
Symptoms of Long-COVID Can Last Up to Two Years After Infection, Say END-VOC Researchers
Almost one in four people infected with SARS-CoV-2 suffered from [...]
T Cells Hold the Line Against New COVID-19 Variants
This study underscores the key role of T cells in [...]
Mpox Outbreak in Africa Can Still be Controlled and Eliminated, Says END-VOC Leader
In a recent comment published in The Lancet, Ibrahim Abubakar [...]
END-VOC Welcomes a New Partner to the Project
This summer, the Instituto de Medicina Molecular (IMM) Joao Lobo [...]
ENDVOC’s Fourth General Assembly in London Shows Great Progress
The ENDVOC consortium is now in a position to step [...]
ENDVOC Researchers Recommend Strenghtening Immunity against COVID-19 in People with Cancer
This is the most exhaustive research carried out so far [...]
